Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More.

JAMA network open

Sommerstein R, Atkinson A, Kuster SP, Vuichard-Gysin D, Harbarth S, Troillet N, Widmer AF.
PMID: 34910149
JAMA Netw Open. 2021 Dec 01;4(12):e2138926. doi: 10.1001/jamanetworkopen.2021.38926.

IMPORTANCE: Many guidelines recommend a weight-adopted dose increase of cefuroxime for surgical antimicrobial prophylaxis (SAP). However, the evidence that this approach is associated with lower rates of surgical site infection (SSI) is limited.OBJECTIVE: To assess whether double-dose cefuroxime SAP...

Cite
Sommerstein R, Atkinson A, Kuster SP, et al. Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More. JAMA Netw Open. 2021;4(12):e2138926doi: 10.1001/jamanetworkopen.2021.38926.
Sommerstein, R., Atkinson, A., Kuster, S. P., Vuichard-Gysin, D., Harbarth, S., Troillet, N., Widmer, A. F. (2021). Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More. JAMA network open, 4(12), e2138926. https://doi.org/10.1001/jamanetworkopen.2021.38926
Sommerstein, Rami, et al. "Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More." JAMA network open vol. 4,12 (2021): e2138926. doi: https://doi.org/10.1001/jamanetworkopen.2021.38926
Sommerstein R, Atkinson A, Kuster SP, Vuichard-Gysin D, Harbarth S, Troillet N, Widmer AF. Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More. JAMA Netw Open. 2021 Dec 01;4(12):e2138926. doi: 10.1001/jamanetworkopen.2021.38926. PMID: 34910149.
Copy Download .nbib Format: NLM
Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR).

Swiss medical weekly

Roelens M, Martin A, Friker B, Sousa FM, Thiabaud A, Vidondo B, Buchter V, Gardiol C, Vonlanthen J, Balmelli C, Battegay M, Berger C, Buettcher M, Cusini A, Flury D, Heininger U, Niederer-Loher A, Riedel T, Schreiber PW, Sommerstein R, Troillet N, Tschudin-Sutter S, Vetter P, Bernhard-Stirnemann S, Corti N, Gaudenz R, Marschall J, Nussbaumer-Ochsner Y, Senn L, Vuichard-Gysin D, Zimmermann P, Zucol F, Iten A, Keiser O.
PMID: 34843180
Swiss Med Wkly. 2021 Nov 24;151:w30105. doi: 10.4414/smw.2021.w30105. eCollection 2021 Nov 22.

BACKGROUND: When the periods of time during and after the first wave of the ongoing SARS-CoV-2/COVID-19 pandemic in Europe are compared, the associated COVID-19 mortality seems to have decreased substantially. Various factors could explain this trend, including changes in...

Cite
Roelens M, Martin A, Friker B, et al. Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR). Swiss Med Wkly. 2021;151:w30105doi: 10.4414/smw.2021.w30105.
Roelens, M., Martin, A., Friker, B., Sousa, F. M., Thiabaud, A., Vidondo, B., Buchter, V., Gardiol, C., Vonlanthen, J., Balmelli, C., Battegay, M., Berger, C., Buettcher, M., Cusini, A., Flury, D., Heininger, U., Niederer-Loher, A., Riedel, T., Schreiber, P. W., Sommerstein, R., Troillet, N., Tschudin-Sutter, S., Vetter, P., Bernhard-Stirnemann, S., Corti, N., Gaudenz, R., Marschall, J., Nussbaumer-Ochsner, Y., Senn, L., Vuichard-Gysin, D., Zimmermann, P., Zucol, F., Iten, A., & Keiser, O. (2021). Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR). Swiss medical weekly, 151w30105. https://doi.org/10.4414/smw.2021.w30105
Roelens, Maroussia, et al. "Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)." Swiss medical weekly vol. 151 (2021): w30105. doi: https://doi.org/10.4414/smw.2021.w30105
Roelens M, Martin A, Friker B, Sousa FM, Thiabaud A, Vidondo B, Buchter V, Gardiol C, Vonlanthen J, Balmelli C, Battegay M, Berger C, Buettcher M, Cusini A, Flury D, Heininger U, Niederer-Loher A, Riedel T, Schreiber PW, Sommerstein R, Troillet N, Tschudin-Sutter S, Vetter P, Bernhard-Stirnemann S, Corti N, Gaudenz R, Marschall J, Nussbaumer-Ochsner Y, Senn L, Vuichard-Gysin D, Zimmermann P, Zucol F, Iten A, Keiser O. Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR). Swiss Med Wkly. 2021 Nov 24;151:w30105. doi: 10.4414/smw.2021.w30105. eCollection 2021 Nov 22. PMID: 34843180.
Copy Download .nbib Format: NLM
Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report From a Multicenter New York Area Institution.

Advances in radiation oncology

Chen WC, Teckie S, Somerstein G, Adair N, Potters L.
PMID: 32395672
Adv Radiat Oncol. 2020 May 11;5(4):621-627. doi: 10.1016/j.adro.2020.04.021. eCollection 2020.

As the coronavirus disease 2019 pandemic spreads around the globe, access to radiation therapy remains critical for patients with cancer. The priority for all radiation oncology departments is to protect the staff and to maintain operations in providing access...

Cite
Chen WC, Teckie S, Somerstein G, et al. Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report From a Multicenter New York Area Institution. Adv Radiat Oncol. 2020;5(4):621-627doi: 10.1016/j.adro.2020.04.021.
Chen, W. C., Teckie, S., Somerstein, G., Adair, N., & Potters, L. (2020). Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report From a Multicenter New York Area Institution. Advances in radiation oncology, 5(4), 621-627. https://doi.org/10.1016/j.adro.2020.04.021
Chen, William C, et al. "Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report From a Multicenter New York Area Institution." Advances in radiation oncology vol. 5,4 (2020): 621-627. doi: https://doi.org/10.1016/j.adro.2020.04.021
Chen WC, Teckie S, Somerstein G, Adair N, Potters L. Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report From a Multicenter New York Area Institution. Adv Radiat Oncol. 2020 May 11;5(4):621-627. doi: 10.1016/j.adro.2020.04.021. eCollection 2020. PMID: 32395672; PMCID: PMC7212958.
Copy Download .nbib Format: NLM
An automated retrospective VAE-surveillance tool for future quality improvement studies.

Scientific reports

Wolffers O, Faltys M, Thomann J, Jakob SM, Marschall J, Merz TM, Sommerstein R.
PMID: 34782637
Sci Rep. 2021 Nov 15;11(1):22264. doi: 10.1038/s41598-021-01402-3.

Ventilator-associated pneumonia (VAP) is a frequent complication of mechanical ventilation and is associated with substantial morbidity and mortality. Accurate diagnosis of VAP relies in part on subjective diagnostic criteria. Surveillance according to ventilator-associated event (VAE) criteria may allow quick...

Cite
Wolffers O, Faltys M, Thomann J, et al. An automated retrospective VAE-surveillance tool for future quality improvement studies. Sci Rep. 2021;11(1):22264doi: 10.1038/s41598-021-01402-3.
Wolffers, O., Faltys, M., Thomann, J., Jakob, S. M., Marschall, J., Merz, T. M., & Sommerstein, R. (2021). An automated retrospective VAE-surveillance tool for future quality improvement studies. Scientific reports, 11(1), 22264. https://doi.org/10.1038/s41598-021-01402-3
Wolffers, Oliver, et al. "An automated retrospective VAE-surveillance tool for future quality improvement studies." Scientific reports vol. 11,1 (2021): 22264. doi: https://doi.org/10.1038/s41598-021-01402-3
Wolffers O, Faltys M, Thomann J, Jakob SM, Marschall J, Merz TM, Sommerstein R. An automated retrospective VAE-surveillance tool for future quality improvement studies. Sci Rep. 2021 Nov 15;11(1):22264. doi: 10.1038/s41598-021-01402-3. PMID: 34782637; PMCID: PMC8593155.
Copy Download .nbib Format: NLM
The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study.

Critical care (London, England)

Damonti L, Kronenberg A, Marschall J, Jent P, Sommerstein R, De Kraker MEA, Harbarth S, Gasser M, Buetti N.
PMID: 34809698
Crit Care. 2021 Nov 22;25(1):403. doi: 10.1186/s13054-021-03814-z.

BACKGROUND: Evidence about the impact of the pandemic of COVID-19 on the incidence rates of blood cultures contaminations and bloodstream infections in intensive care units (ICUs) remains scant. The objective of this study was to investigate the nationwide epidemiology...

Cite
Damonti L, Kronenberg A, Marschall J, et al. The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study. Crit Care. 2021;25(1):403doi: 10.1186/s13054-021-03814-z.
Damonti, L., Kronenberg, A., Marschall, J., Jent, P., Sommerstein, R., De Kraker, M. E. A., Harbarth, S., Gasser, M., & Buetti, N. (2021). The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study. Critical care (London, England), 25(1), 403. https://doi.org/10.1186/s13054-021-03814-z
Damonti, Lauro, et al. "The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study." Critical care (London, England) vol. 25,1 (2021): 403. doi: https://doi.org/10.1186/s13054-021-03814-z
Damonti L, Kronenberg A, Marschall J, Jent P, Sommerstein R, De Kraker MEA, Harbarth S, Gasser M, Buetti N. The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study. Crit Care. 2021 Nov 22;25(1):403. doi: 10.1186/s13054-021-03814-z. PMID: 34809698; PMCID: PMC8607066.
Copy Download .nbib Format: NLM
Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Fröhlich GM, De Kraker MEA, Abbas M, Keiser O, Thiabaud A, Roelens M, Cusini A, Flury D, Schreiber PW, Buettcher M, Corti N, Vuichard-Gysin D, Troillet N, Sauser J, Gaudenz R, Damonti L, Balmelli C, Iten A, Widmer A, Harbarth S, Sommerstein R.
PMID: 34991775
Euro Surveill. 2022 Jan;27(1). doi: 10.2807/1560-7917.ES.2022.27.1.2001848.

BackgroundSince the onset of the COVID-19 pandemic, the disease has frequently been compared with seasonal influenza, but this comparison is based on little empirical data.AimThis study compares in-hospital outcomes for patients with community-acquired COVID-19 and patients with community-acquired influenza...

Cite
Fröhlich GM, De Kraker MEA, Abbas M, et al. Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19. Euro Surveill. 2022;27(1)doi: 10.2807/1560-7917.ES.2022.27.1.2001848.
Fröhlich, G. M., De Kraker, M. E. A., Abbas, M., Keiser, O., Thiabaud, A., Roelens, M., Cusini, A., Flury, D., Schreiber, P. W., Buettcher, M., Corti, N., Vuichard-Gysin, D., Troillet, N., Sauser, J., Gaudenz, R., Damonti, L., Balmelli, C., Iten, A., Widmer, A., Harbarth, S., & Sommerstein, R. (2022). Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 27(1), . https://doi.org/10.2807/1560-7917.ES.2022.27.1.2001848
Fröhlich, Georg Marcus, et al. "Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19." Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin vol. 27,1 (2022). doi: https://doi.org/10.2807/1560-7917.ES.2022.27.1.2001848
Fröhlich GM, De Kraker MEA, Abbas M, Keiser O, Thiabaud A, Roelens M, Cusini A, Flury D, Schreiber PW, Buettcher M, Corti N, Vuichard-Gysin D, Troillet N, Sauser J, Gaudenz R, Damonti L, Balmelli C, Iten A, Widmer A, Harbarth S, Sommerstein R. Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19. Euro Surveill. 2022 Jan;27(1). doi: 10.2807/1560-7917.ES.2022.27.1.2001848. PMID: 34991775.
Copy Download .nbib Format: NLM
Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More.

JAMA network open

Sommerstein R, Atkinson A, Kuster SP, Vuichard-Gysin D, Harbarth S, Troillet N, Widmer AF.
PMID: 34910149
JAMA Netw Open. 2021 Dec 01;4(12):e2138926. doi: 10.1001/jamanetworkopen.2021.38926.

IMPORTANCE: Many guidelines recommend a weight-adopted dose increase of cefuroxime for surgical antimicrobial prophylaxis (SAP). However, the evidence that this approach is associated with lower rates of surgical site infection (SSI) is limited.OBJECTIVE: To assess whether double-dose cefuroxime SAP...

Cite
Sommerstein R, Atkinson A, Kuster SP, et al. Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More. JAMA Netw Open. 2021;4(12):e2138926doi: 10.1001/jamanetworkopen.2021.38926.
Sommerstein, R., Atkinson, A., Kuster, S. P., Vuichard-Gysin, D., Harbarth, S., Troillet, N., Widmer, A. F. (2021). Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More. JAMA network open, 4(12), e2138926. https://doi.org/10.1001/jamanetworkopen.2021.38926
Sommerstein, Rami, et al. "Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More." JAMA network open vol. 4,12 (2021): e2138926. doi: https://doi.org/10.1001/jamanetworkopen.2021.38926
Sommerstein R, Atkinson A, Kuster SP, Vuichard-Gysin D, Harbarth S, Troillet N, Widmer AF. Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More. JAMA Netw Open. 2021 Dec 01;4(12):e2138926. doi: 10.1001/jamanetworkopen.2021.38926. PMID: 34910149; PMCID: PMC8674749.
Copy Download .nbib Format: NLM
Droplet precautions on-site (DroPS) during the influenza season 2018/2019: a possible alternative to single room isolation for respiratory viral infections.

Antimicrobial resistance and infection control

Birrer M, Perrig M, Hobi F, Gfeller C, Atkinson A, Egger M, Bartholdi C, Aujesky D, Marschall J, Sommerstein R.
PMID: 35000584
Antimicrob Resist Infect Control. 2022 Jan 09;11(1):2. doi: 10.1186/s13756-021-01038-y.

BACKGROUND: The guideline-driven and widely implemented single room isolation strategy for respiratory viral infections (RVI) such as influenza or respiratory syncytial virus (RSV) can lead to a shortage of available hospital beds. We discuss our experience with the introduction...

Cite
Birrer M, Perrig M, Hobi F, et al. Droplet precautions on-site (DroPS) during the influenza season 2018/2019: a possible alternative to single room isolation for respiratory viral infections. Antimicrob Resist Infect Control. 2022;11(1):2doi: 10.1186/s13756-021-01038-y.
Birrer, M., Perrig, M., Hobi, F., Gfeller, C., Atkinson, A., Egger, M., Bartholdi, C., Aujesky, D., Marschall, J., & Sommerstein, R. (2022). Droplet precautions on-site (DroPS) during the influenza season 2018/2019: a possible alternative to single room isolation for respiratory viral infections. Antimicrobial resistance and infection control, 11(1), 2. https://doi.org/10.1186/s13756-021-01038-y
Birrer, Michèle, et al. "Droplet precautions on-site (DroPS) during the influenza season 2018/2019: a possible alternative to single room isolation for respiratory viral infections." Antimicrobial resistance and infection control vol. 11,1 (2022): 2. doi: https://doi.org/10.1186/s13756-021-01038-y
Birrer M, Perrig M, Hobi F, Gfeller C, Atkinson A, Egger M, Bartholdi C, Aujesky D, Marschall J, Sommerstein R. Droplet precautions on-site (DroPS) during the influenza season 2018/2019: a possible alternative to single room isolation for respiratory viral infections. Antimicrob Resist Infect Control. 2022 Jan 09;11(1):2. doi: 10.1186/s13756-021-01038-y. PMID: 35000584.
Copy Download .nbib Format: NLM
An automated retrospective VAE-surveillance tool for future quality improvement studies.

Scientific reports

Wolffers O, Faltys M, Thomann J, Jakob SM, Marschall J, Merz TM, Sommerstein R.
PMID: 34782637
Sci Rep. 2021 Nov 15;11(1):22264. doi: 10.1038/s41598-021-01402-3.

Ventilator-associated pneumonia (VAP) is a frequent complication of mechanical ventilation and is associated with substantial morbidity and mortality. Accurate diagnosis of VAP relies in part on subjective diagnostic criteria. Surveillance according to ventilator-associated event (VAE) criteria may allow quick...

Cite
Wolffers O, Faltys M, Thomann J, et al. An automated retrospective VAE-surveillance tool for future quality improvement studies. Sci Rep. 2021;11(1):22264doi: 10.1038/s41598-021-01402-3.
Wolffers, O., Faltys, M., Thomann, J., Jakob, S. M., Marschall, J., Merz, T. M., & Sommerstein, R. (2021). An automated retrospective VAE-surveillance tool for future quality improvement studies. Scientific reports, 11(1), 22264. https://doi.org/10.1038/s41598-021-01402-3
Wolffers, Oliver, et al. "An automated retrospective VAE-surveillance tool for future quality improvement studies." Scientific reports vol. 11,1 (2021): 22264. doi: https://doi.org/10.1038/s41598-021-01402-3
Wolffers O, Faltys M, Thomann J, Jakob SM, Marschall J, Merz TM, Sommerstein R. An automated retrospective VAE-surveillance tool for future quality improvement studies. Sci Rep. 2021 Nov 15;11(1):22264. doi: 10.1038/s41598-021-01402-3. PMID: 34782637; PMCID: PMC8593155.
Copy Download .nbib Format: NLM
Interferon-driven deletion of antiviral B cells at the onset of chronic infection.

Science immunology

Fallet B, Narr K, Ertuna YI, Remy M, Sommerstein R, Cornille K, Kreutzfeldt M, Page N, Zimmer G, Geier F, Straub T, Pircher H, Larimore K, Greenberg PD, Merkler D, Pinschewer DD.
PMID: 27872905
Sci Immunol. 2016 Oct 21;1(4). doi: 10.1126/sciimmunol.aah6817.

Inadequate antibody responses and perturbed B cell compartments represent hallmarks of persistent microbial infections, but the mechanisms whereby persisting pathogens suppress humoral immunity remain poorly defined. Using adoptive transfer experiments in the context of a chronic lymphocytic choriomeningitis virus...

Cite
Fallet B, Narr K, Ertuna YI, et al. Interferon-driven deletion of antiviral B cells at the onset of chronic infection. Sci Immunol. 2016;1(4)doi: 10.1126/sciimmunol.aah6817.
Fallet, B., Narr, K., Ertuna, Y. I., Remy, M., Sommerstein, R., Cornille, K., Kreutzfeldt, M., Page, N., Zimmer, G., Geier, F., Straub, T., Pircher, H., Larimore, K., Greenberg, P. D., Merkler, D., & Pinschewer, D. D. (2016). Interferon-driven deletion of antiviral B cells at the onset of chronic infection. Science immunology, 1(4), . https://doi.org/10.1126/sciimmunol.aah6817
Fallet, Benedict, et al. "Interferon-driven deletion of antiviral B cells at the onset of chronic infection." Science immunology vol. 1,4 (2016). doi: https://doi.org/10.1126/sciimmunol.aah6817
Fallet B, Narr K, Ertuna YI, Remy M, Sommerstein R, Cornille K, Kreutzfeldt M, Page N, Zimmer G, Geier F, Straub T, Pircher H, Larimore K, Greenberg PD, Merkler D, Pinschewer DD. Interferon-driven deletion of antiviral B cells at the onset of chronic infection. Sci Immunol. 2016 Oct 21;1(4). doi: 10.1126/sciimmunol.aah6817. PMID: 27872905; PMCID: PMC5115616.
Copy Download .nbib Format: NLM
Distribution of pathogens and antimicrobial resistance in bacteraemia according to hospitalization duration: a nationwide surveillance study in Switzerland.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Buetti N, Marschall J, Timsit JF, Atkinson A, Kronenberg A, Sommerstein R.
PMID: 33933567
Clin Microbiol Infect. 2021 Dec;27(12):1820-1825. doi: 10.1016/j.cmi.2021.04.025. Epub 2021 Apr 30.

OBJECTIVES: Changing microorganism distributions and decreasing antibiotic susceptibility with increasing length of hospital stay have been demonstrated for the colonization or infection of selected organ systems. We wanted to describe microorganism distribution or antibiotic resistance in bacteraemia according to...

Cite
Buetti N, Marschall J, Timsit JF, et al. Distribution of pathogens and antimicrobial resistance in bacteraemia according to hospitalization duration: a nationwide surveillance study in Switzerland. Clin Microbiol Infect. 2021;27(12):1820-1825doi: 10.1016/j.cmi.2021.04.025.
Buetti, N., Marschall, J., Timsit, J. F., Atkinson, A., Kronenberg, A., Sommerstein, R. (2021). Distribution of pathogens and antimicrobial resistance in bacteraemia according to hospitalization duration: a nationwide surveillance study in Switzerland. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(12), 1820-1825. https://doi.org/10.1016/j.cmi.2021.04.025
Buetti, Niccolò, et al. "Distribution of pathogens and antimicrobial resistance in bacteraemia according to hospitalization duration: a nationwide surveillance study in Switzerland." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 27,12 (2021): 1820-1825. doi: https://doi.org/10.1016/j.cmi.2021.04.025
Buetti N, Marschall J, Timsit JF, Atkinson A, Kronenberg A, Sommerstein R. Distribution of pathogens and antimicrobial resistance in bacteraemia according to hospitalization duration: a nationwide surveillance study in Switzerland. Clin Microbiol Infect. 2021 Dec;27(12):1820-1825. doi: 10.1016/j.cmi.2021.04.025. Epub 2021 Apr 30. PMID: 33933567.
Copy Download .nbib Format: NLM
Three-dimensional imager.

Applied optics

Caulfield HJ, Somerstein S.
PMID: 20168577
Appl Opt. 1977 Mar 01;16(3):774. doi: 10.1364/AO.16.000774.

A mode-locked laser, a rotating beam splitter, and a streak camera are the primary components of an imager with the ability to record three-dimensional images of remote (up to several kilometers) objects in real time in broad daylight. Immediate...

Cite
Caulfield HJ, Somerstein S. Three-dimensional imager. Appl Opt. 1977;16(3):774doi: 10.1364/AO.16.000774.
Caulfield, H. J., & Somerstein, S. (1977). Three-dimensional imager. Applied optics, 16(3), 774. https://doi.org/10.1364/AO.16.000774
Caulfield, H J, and Somerstein, S. "Three-dimensional imager." Applied optics vol. 16,3 (1977): 774. doi: https://doi.org/10.1364/AO.16.000774
Caulfield HJ, Somerstein S. Three-dimensional imager. Appl Opt. 1977 Mar 01;16(3):774. doi: 10.1364/AO.16.000774. PMID: 20168577.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries